Literature DB >> 1289141

Fields, DVLC and panretinal photocoagulation.

S A Buckley1, L Jenkins, L Benjamin.   

Abstract

Laser panretinal photocoagulation (PRP) reduces visual loss in proliferative diabetic retinopathy but decreases peripheral retinal function. The Driver and Vehicle Licensing Centre (DVLC) states that when a patient volunteers that he or she has had photocoagulation, a questionnaire will then be sent to the patient's diabetic physician who can refer the patient for formal field testing. Of 30 patients who had PRP, 15 failed DVLC visual field regulations using the Esterman binocular field test on the Humphrey field analyser. The failures were more likely to have had treatment with a xenon laser, but there was no difference between the groups as regards age, number of burns or whether an argon or diode laser was used. The patients who failed were more likely to be hypertensive (p = 0.04). Two patients with unilateral PRP could not meet the driving regulations because of other field defects. Diabetes itself causes field defects, and therefore even with small amounts of laser, formal field testing may be necessary.

Entities:  

Mesh:

Year:  1992        PMID: 1289141     DOI: 10.1038/eye.1992.134

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  5 in total

1.  Driving, glaucoma, and the law. Diabetic patients must also satisfy regulations.

Authors:  J H Casey; C J McLean; J Jagger
Journal:  BMJ       Date:  1995-01-07

2.  Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis.

Authors:  R P Mills
Journal:  Trans Am Ophthalmol Soc       Date:  1998

3.  Quality of Life in People with Diabetic Retinopathy: Indian Study.

Authors:  Datson Marian Pereira; Amish Shah; May D'Souza; Paul Simon; Thomas George; Nameeth D'Souza; Sucharitha Suresh; Manjeshwar Shrinath Baliga
Journal:  J Clin Diagn Res       Date:  2017-04-01

4.  Long-Term Visual Function Effects of Pan-Retinal Photocoagulation in Diabetic Retinopathy and Its Impact in Real Life.

Authors:  Pedro Manuel Baptista; Ana Ambrósio Marta; João Heitor; Diana José; Daniel Almeida; António Ribeiro; Irene Barbosa
Journal:  Diabetes Metab Syndr Obes       Date:  2021-03-19       Impact factor: 3.168

5.  Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.

Authors:  Zhale Rajavi; Sare Safi; Mohammad Ali Javadi; Mohsen Azarmina; Siamak Moradian; Morteza Entezari; Ramin Nourinia; Hamid Ahmadieh; Armin Shirvani; Saeid Shahraz; Alireza Ramezani; Mohammad Hossein Dehghan; Mohsen Shahsavari; Masoud Soheilian; Homayoun Nikkhah; Hossein Ziaei; Hasan Behboudi; Fereydoun Farrahi; Khalil Ghasemi Falavarjani; Mohammad Mehdi Parvaresh; Hamid Fesharaki; Majid Abrishami; Nasser Shoeibi; Mansour Rahimi; Alireza Javadzadeh; Reza Karkhaneh; Mohammad Riazi-Esfahani; Masoud Reza Manaviat; Alireza Maleki; Bahareh Kheiri; Faegheh Golbafian
Journal:  J Ophthalmic Vis Res       Date:  2016 Oct-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.